5O5P

Poliovirus type 3 (strain Saukett) stabilized virus-like particle in complex with the pocket factor compound GPP3


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.10 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.

Marsian, J.Fox, H.Bahar, M.W.Kotecha, A.Fry, E.E.Stuart, D.I.Macadam, A.J.Rowlands, D.J.Lomonossoff, G.P.

(2017) Nat Commun 8: 245-245

  • DOI: 10.1038/s41467-017-00090-w
  • Primary Citation of Related Structures:  
    5O5P, 5O5B

  • PubMed Abstract: 
  • Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since antiquity. PV occurs in two distinct antigenic forms, D and C, of which only the D form elicits a robust neutralizing response. Developing a synthetically produced stabilized virus-like particle (sVLP)-based vaccine with D antigenicity, without the drawbacks of current vaccines, will be a major step towards the final eradication of poliovirus ...

    Poliovirus (PV) is the causative agent of poliomyelitis, a crippling human disease known since antiquity. PV occurs in two distinct antigenic forms, D and C, of which only the D form elicits a robust neutralizing response. Developing a synthetically produced stabilized virus-like particle (sVLP)-based vaccine with D antigenicity, without the drawbacks of current vaccines, will be a major step towards the final eradication of poliovirus. Such a sVLP would retain the native antigenic conformation and the repetitive structure of the original virus particle, but lack infectious genomic material. In this study, we report the production of synthetically stabilized PV VLPs in plants. Mice carrying the gene for the human PV receptor are protected from wild-type PV when immunized with the plant-made PV sVLPs. Structural analysis of the stabilized mutant at 3.6 Å resolution by cryo-electron microscopy and single-particle reconstruction reveals a structure almost indistinguishable from wild-type PV3.Despite the success of current vaccination against poliomyelitis, safe, cheap and effective vaccines remain sought for continuing eradication effort. Here the authors use plants to express stabilized virus-like particles of type 3 poliovirus that can induce a protective immune response in mice transgenic for the human poliovirus receptor.


    Organizational Affiliation

    John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK. George.Lomonossoff@jic.ac.uk.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteins, VP1 1300Human poliovirus 3Mutation(s): 2 
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteins, VP2 2271Human poliovirus 3Mutation(s): 3 
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
Capsid proteins, VP3 3238Human poliovirus 3Mutation(s): 2 
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetailsImage
Genome polyprotein 469Human poliovirus 3Mutation(s): 0 
EC: 3.4.22.29 (PDB Primary Data), 3.6.1.15 (PDB Primary Data), 3.4.22.28 (PDB Primary Data), 2.7.7.48 (PDB Primary Data)
Find proteins for Q84895 (Human poliovirus 3)
Explore Q84895 
Go to UniProtKB:  Q84895
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
9LW
Query on 9LW

Download Ideal Coordinates CCD File 
1
1-[5-[4-(ethoxyiminomethyl)phenoxy]-3-methyl-pentyl]-3-pyridin-4-yl-imidazol-2-one
C23 H28 N4 O3
JVWDSRHSJUZDAL-BWAHOGKJSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.10 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
WHO/Gates foundationUnited KingdomRG.IMCB.I8-TSA-083

Revision History  (Full details and data files)

  • Version 1.0: 2017-07-12
    Type: Initial release
  • Version 1.1: 2017-08-23
    Changes: Database references
  • Version 1.2: 2017-08-30
    Changes: Data collection, Refinement description
  • Version 1.3: 2019-10-02
    Changes: Data collection, Other